A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence. Results of a phase 3 ...
Mountain View, CA, May 16, 2023 (GLOBE NEWSWIRE) -- Health Gorilla, a leading Health Information Network and interoperability provider, has launched ADT Data, a new product delivering real-time event ...
Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984 Individual patient data from 12 randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results